jpcapela.bsky.social
Farmacêutico, PhD em Toxicologia, Professor Uni. Farmacologia e Toxicologia 🧪🔬🧠🇵🇹
Pharmacist, PhD in Toxicology, Uni. Professor of Pharmacology and Toxicology 🧪🔬🧠 🇪🇺
Views my own!
https://scholar.google.pt/citations?user=xlO_SBQAAAAJ&hl=pt-PT
28 posts
150 followers
47 following
Regular Contributor
Conversation Starter
comment in response to
post
Clinical trials back then agreed in a minor, but statistically significant effect. The problems are the adverse events like cardiovascular and potential abuse.
comment in response to
post
More one good news for science 🧪
comment in response to
post
That brings me back good memories, when I stayed until late hours I the lab✌️🧠🧪
comment in response to
post
Here is a paper, already with some years, that reviews the potential neurotoxicity of MDMA.
#PharmSky
#ToxSky
#MedSky
#NeuroSky
🧪
link.springer.com/article/10.1...
comment in response to
post
MDMA could be helpful in PSTD or other brain disorders. There should be clinical trials not only showing effectiveness but also safety, not only in the short but also in the long term. Caution is required due to the potential neurotoxicity and hepatotoxic actions of MDMA and it’s metabolites. 🧪
comment in response to
post
Mais uma investigadora de renome a dizer o óbvio! O financiamento da FCT no próxima OE vai baixar e seguramente no ano seguinte será igual. Se já estávamos com um nível baixo de financiamento da FCT, vamos ficar ainda pior!
comment in response to
post
Great. Add me, thanks.
comment in response to
post
Thanks for your interest. Bit amphetamine and methylphenidate are used in ADHD. So in controlled doses and settings they can be therapeutically useful. The major problem with these two drugs are cardiovascular, and trials reveal no major adverse effects that could undermine its use.
comment in response to
post
I understand your concerns regarding the cardiovascular adverse effects, which no doubt should be given attention. The clinical trails did not show that adverse effects under control doses and settings were a problem. They did reveal mixed results, some improved others detailed no improvement.
comment in response to
post
Thanks for your interest in our work. In fact regarding the brain it makes sense the use of stimulants for this neurological disorders. In particular methylphenidate, that is used to treat ADHD, has been given more attention for stroke or TBI.
comment in response to
post
Muitos parabéns por estale excelente programa, que muito aprecio ouvir.
comment in response to
post
Please add me! Thanks 🙏
comment in response to
post
Thanks
comment in response to
post
Thanks 🙏🤗
comment in response to
post
Hi! Can you place me in the starter pack Pharmacy and Pharmacology? Thanks
comment in response to
post
🧪